Advocates on Steps of Congress 2013
Please leave this field empty
Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
eletter banner.jpg
eLetter #643 | January 22, 2016  

Seattle Children's Hospital added to Scleroderma Foundation Research Center List

logo_main_sch.gifSeattle Children's has the only rheumatology program in the Pacific Northwest dedicated to children and teens, 17 and under.  At Children's, a team of experts - including doctors, physicall and occupational therapists, nurses and social workers - will see you child. 

Click here to Foundation's entire list of research centers >>

Living Your Life with Rheumatoid Arthritis (RA)

Hand-with-rheumatoid-arthritis1.jpgAre you living with RA?  Our friends at the Rheumatoid Arthritis Support Network provide up-to-date information and resources for patients.  Their goal is simple.  They want RA patients to know their options and fully understand their diagnosis.

Click here for more >>

Funding Opportunities for 2016 from The Defense Health Program

DODc.gifThe Fiscal Year 2016 (FY16) Defense Appropriations Act provides $278.7 million to the Department of Defense Peer Reviewed Medical Research Program (PRMRP).  The vision of the PRMRP is to improve the health and well-being of all military Service members, Veterans and beneficiaries. 

Click here to read the entire press release>>

Progress and Collaboration on Clinical Trials

aclinicaltrials.jpgEver wonder how the FDA approves certain medical products?  There are few responsibilities more important than reviewing the design and outcomes of clinical trials.  The FDA has made progress and will continue the forward momentum in the years to come.

Click here to read more >>

Donate Button
Quick Links
Advocacy
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Store
Home
facebook_32.png
twitter_32.png
Youtube_32x32.png

Actelion 2016 sponsor
2016 Bayer Logo


 

 

Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2017 All rights reserved.